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There are a great number of reports with assertions that oxidative stress is produced by organophosphorus compound (OPC)
poisoning and is a cofactor of mortality and morbidity in OPC toxicity. In addition, antioxidants have been suggested as adjuncts
to standard therapy. However, there is no substantial evidence for the benefit of the use of antioxidants in survival after acute
intoxication of OPCs. The present study was conducted to assess the effectiveness of three non-enzymatic antioxidants (NEAOs),
N-acetylcysteine (NAC), glutathione (GSH), and ascorbic acid (AA), in acute intoxication of adult maleWister rats with paraoxon.
The efficacy of the antioxidants was estimated as both a pretreatment and a concurrent application along with the standard oxime,
pralidoxime (2-PAM). Relative risk of death after 48 hours of application was estimated by Cox regression analysis. The results
revealed no benefit of either testedNEAO to the improvement in survival of experimental rats.The application of these antioxidants
was found to be deleterious when administered along with pralidoxime compared to the treatment with pralidoxime alone. It has
been concluded that the tested non-enzymatic antioxidants are not useful in acute toxicity for improving survival rates. However,
the individual toxic dynamics of diversified OPCs should not be overlooked and further studies with different OPCs are suggested.
1. Introduction
There are various groups of organophosphorus compounds
which are structurally and toxicologically different. Organo-
phosphorus compounds account for hundreds of thousands
of deaths worldwide every year and for even a greater
number of casualties [1]. The standard medical treatment
of organophosphorus poisoning is atropine + oxime + ben-
zodiazepines, for example, diazepam [2]. In recent years,
oxidative stress has been described as one of the co-lethal
factors in organophosphorus-induced poisoning [3–11]. A
number of clinical studies also suggested the beneficial role
of antioxidants in acute OPC poisoning [12–14]. However,
a conflicting review was reported by Nurulain et al. [15].
It is noteworthy that among the large number of published
articles on the topic, depicting the beneficial role of the
use of antioxidants, the mortality improvement studies with
acute poisoning are scarcely reported. The assumption and
conclusion for oxidative stress and use of antioxidants in
OPC poisoning are mainly based on cell/organ level of
investigations. Secondly, studies were largely carried out on
moderately or highly toxic compounds with sublethal doses
or LD
50
dose.
The objective of the present study was to assess the use of
three common NEAOs, NAC, GSH, and AA as adjuncts to
oxime and without oxime in acute poisoning with survival
outcome. Paraoxon is an extremely toxic OPC and one of
the most potent acetylcholinesterase inhibiting insecticide
Hindawi Publishing Corporation
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 329306, 6 pages
http://dx.doi.org/10.1155/2015/329306
2 Oxidative Medicine and Cellular Longevity
available. It is around 70% as potent as the nerve agent sarin.
It is an active metabolite of the insecticide parathion. The
purpose of the study was to quantify the protection incurred
by NEAO in case of acute intoxication by an extremely toxic
OPC, paraoxon.
2. Materials and Methods
2.1. Experimental Animals. During the entire experiment, the
“Guiding Principles in theCare of andUse of LaboratoryAni-
mals” have been observed. Animals were handled, ethically
treated, and humanly killed as per the rules and instructions
of the Ethical Committee. All studies were performed with
the approval of the Institutional Ethical Committee (A29/12).
The original stock of Wistar rats was purchased from Harlan
Laboratories (Harlan Laboratories, Oxon, England). The
animals used in the present studies were bred at our own
Animal Facility from the original stock. Adult male rats
(average weight ± SD: 259 ± 13 g; 95% confidence interval:
258 g–260 g) were housed in polypropylene cages (43 × 22.5
× 20.5 cm3; six rats/cage) in climate- and access-controlled
rooms (23 ± 1∘C; 50 ± 4% humidity). The day/night cycle
was 12 h/12 h. Food and water were available ad libitum. The
food was purchased from Emirates Feed Factory (AbuDhabi,
UAE) which is a standard maintenance diet for rats.
2.2. Chemicals. Paraoxon (POX) stock solution (100mM)
was prepared in dry acetone. Working solution for i.p. appli-
cation was prepared ex tempore by diluting stock solution
with saline. The other solutions were prepared before experi-
ment. All the chemicals were purchased from Sigma-Aldrich
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany).
2.3. Choice of Dosage and Treatment. The acute dosage of
paraoxon (≈LD
75
and 2x LD
75
) and safe dose of pralidoxime
(1/2 of LD
1
) against Wister rats were selected according
to Nurulain et al. [16]. The NAC was used according to
Yurumez et al. [3] who described the effective dose in similar
experiments with mice. GSH was used according to Jiang
et al. [17] where the dose was found to be beneficial in
methyl parathion toxicity. Antunes et al. [18] used 50mg/kg
body weight AA with positive outcome. The average body
weight of the animals was ≈250 g. Antioxidants dosage was
based on previous studies but their safety profile was checked
and found to be non-lethal. The i.p. LD
50
for NAC against
rats was 1205mg/kg body weight [19]. The i.p. LD
50
for
AA and GSH could not be retrieved. However, i.p. LD
50
of
AA and GSH against mouse was reported in the literature
as 10 g/kg body weight [20] and 4.020 g/kg body weight
[21] (LookChem.com), respectively. The intravenous (faster
systemic circulation than i.p.) LD
50
for ascorbic acid against
rat was reported as 1.0 g/kg [22]. All the compounds were
injected i.p. at different anatomical sites. I.p. injection was
opted because it enables the fast systemic circulation com-
pared to intramuscular or oral administration and suitable in
quantifying the true effect of the compounds. In concurrent
application, all the three injections were delivered within one
minute in the following order: POX, 2-PAM, and antioxidant.
2.4. Reference Group
Only Paraoxon Exposure. Animals received i.p. injections of
paraoxon, in a dosage of 1𝜇mol = 272𝜇g (1.09mg/kg average
body weight; ≈LD
75
), and 2 𝜇mol = 544 𝜇g (2.18mg/kg
average body weight; 2x LD
75
), diluted in 500 𝜇L saline
solution.
Pralidoxime (2-PAM). 50𝜇mol/rat = 8.63mg/rat (=33.5mg/
kg average body weight).
N-Acetylcysteine (NAC). 275𝜇mol/rat = 45mg/rat (=225mg/
kg average body weight).
Glutathione Reduced Form (GSH). 490𝜇mol/rat = 150mg/rat
(750mg/kg body weight).
Ascorbic Acid (AA). 285 𝜇mol/rat = 50mg/rat (195mg/kg
body weight).
2.5. Treatment Groups. There were four groups, consisting of
6 rats per compound. Group 1 received only paraoxon; Group
2 received POX + 2-PAM; Group 3 received POX + 2-PAM
+ NAC; Group 4 received NAC 60 minutes before POX + 2-
PAM.The same groupingswere appliedwithGSHandAAbut
pretreatmentwas 90minutes and 30minutes before POX+ 2-
PAM, respectively.There was a control group of POX +NAC,
POX + GSH, and POX + AA. The animals were monitored
for 48 hours andmortality was recorded at 30 minutes, 1, 2, 3,
4, 24, and 48 hours correspondingly. The pretreatment time
points for NAC, GSH, and AA are based on their different
approximate pharmacokinetic properties.
2.6. Statistical Analysis. Statistical analysis was performed on
the mortality data of four cycles. Mortality data were com-
pared and, for each of the seven time points, the respective
hazards ratios (relative risks of death) were estimated using
the Cox proportional hazards model [23]. Both paraoxon
dose and groups (with Group 1, i.e., no pretreatment, as the
reference category) were treated as categorical variables. Sub-
sequently, the area under the RR-time curve was determined
andpair-wise comparisons (Mann-Whitney𝑈-test) were per-
formed. No Bonferroni’s correction formultiple comparisons
was applied, and ≤0.05 was considered significant. The SPSS
21.0 (SPSS Inc., Chicago, IL, USA) software package was used
for all statistical evaluations.
3. Results
The relative risk of death at the seven time points (30min,
1, 2, 3, 4, 24, and 48 h), estimated by Cox [23] analysis
in simultaneous oxime and antioxidant-treated animals is
depicted in Figure 1 and Table 3. Table 1 shows the percentage
of mortalities at different time points of observation. RR
was compared with untreated animals (Group 1, RR =
1) and adjusted for paraoxon dose (high/low). Statistical
comparison was performed on the cumulative relative risk,
that is, the area under the RR-time curve. Simultaneous
pralidoxime treatment significantly reduced the paraoxon-
induced mortality, RR; 0.33 ± 0.03 (𝑃 < 0.05) as compared to
the no-treatment group (G1; paraoxon only). Simultaneous
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Table 1: Mortality [%] after concurrent application of paraoxon, pralidoxime, and NEAO.
Groups (G) POX dose 𝜇mol/rat 30min 1 hour 2 hours 3 hours 4 hours 24 hours 48 hours
G1: POX only 1/2 79/96 83/96 88/96 88/96 88/96 88/96 88/96
G2: POX + PAM + NAC 1/2 42/78 50/78 67/89 71/89 71/89 79/89 83/94
G3: POX + NAC 1/2 92/100 92/100 100/100 100/100 100/100 100/100 100/100
G4: POX + PAM 1/2 8/75 8/79 13/79 17/79 25/79 25/83 29/83
G5: POX + PAM + GSH 1/2 75/75 83/75 92/83 92/92 92/96 92/96 96/96
G6: POX + GSH 1/2 100/100 100/100 100/100 100/100 100/100 100/100 100/100
G7: POX + PAM + AA 1/2 67/83 67/88 79/88 83/92 88/92 92/92 92/92
G8: POX + AA 1/2 75/100 88/100 88/100 88/100 88/100 88/100 88/100
0
0.2
0.4
0.6
0.8
1
1.2
1.4
30 60 120 180 240 1440 2880
Re
la
tiv
e r
isk
Time (min)
POX only
(POX + PAM) + NAC
POX + NAC
POX + PAM
(POX + PAM) + GLU
POX + GLU
(POX + PAM) + AA
POX + AA
Figure 1: Cumulative relative risk of death overtime after coap-
plication of compounds. Cumulative relative risk (RR) of death
overtime with simultaneous intraperitoneal (i.p.) injection of POX,
PAM and NAC, and GSH and AA. The legends on the side are
depicting the treatment groups. RR was estimated by Cox [23]
analysis, adjusted for POX dose (high/low) for each of the time
points examined (30min and 1, 2, 3, 4, 24, and 48 h). Best protection
was conferred by simultaneous PAM treatment only and poor
protection was estimated for all non-enzymatic treatment alone.
Efficacy of PAMwas estimated to decrement when co-administered
with antioxidants.
treatment of NEAO yielded no significant protection. RR
was 1.04 ± 0.04, 1.08 ± 0.03, and 0.85 ± 0.28 for NAC,
GSH, and AA treatment, respectively. When antioxidants
were administered together with PAM, AA treatment group
produced statistically significantly higher mortality (RR 1.30
± 0.12; 𝑃 < 0.014) than no-treatment group, POX. NAC and
GSH applied concurrently with PAM reduced the mortality
in comparison with no-treatment group. Pattern of RR for
pretreatment with antioxidants was almost the same as
mentioned earlier (Figure 2, Tables 2 and 4); that is, only
PAM pretreatment provided significant protection (RR 0.34
± 0.03; 𝑃 < 0.05). Antioxidant pretreatment without PAM
yielded poor protection. RR estimated for NAC was 1.31 ±
0.24; GSH 0.93 ± 0.30; and AA 1.09 ± 0.33. The PAM efficacy
was found to be decreasedwhen animals were pretreatedwith
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Figure 2: Cumulative relative risk of death over time with pretreat-
ment of compounds. Cumulative relative risk (RR) of death over
time with pretreatment, intraperitoneal injections of antioxidants
followed by i.p. administration of POX and PAM. The legends on
the side are depicting the treatment groups. RR was estimated by
Cox [23] analysis, adjusted for POX dose (high/low) for each of the
time points examined (30min, after 30min, 1, 2, 3, 4, 24, and 48 h).
Best protection was conferred by PAM pretreatment only followed
by GSH pretreatment. Efficacy of PAM was estimated to decrement
when administered with antioxidants. B/F denotes before.
antioxidants. RR values were 0.63 ± 0.15 for NAC, 0.93 ±
0.30 and 1.29 ± 0.0.18 for AA pretreatment, respectively, in
comparison with RR 0.47 ± 0.17 for POX + PAM.
4. Discussion
The present study demonstrates the non-effectiveness of the
three NEAOs for paraoxon-induced acute toxicity. Non-
efficacy was observed in both the pre- and the posttreatment
of antioxidants. Recently, it has been documented in the
literature that oxidative stress is a co-lethal factor of OPC-
induced poising, in addition to AChE inhibition. Moreover,
uses of antioxidants have been recommended as adjunct
treatment to OPC poisoning.The biochemical estimations of
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Table 2: Mortality [%] after pretreatments of NEAO and co-application of paraoxon and pralidoxime.
Groups (G) POX DOSE (𝜇mol/rat) 30min 1 hour 2 hours 3 hours 4 hours 24 hours 48 hours
G1: POX only 1/2 79/92 83/92 88/92 88/92 88/92 88/92 88/92
G2: PAM before POX 1/2 4/42 17/46 17/46 17/50 17/58 17/71 17/75
G3: NAC before POX 1/2 94/96 94/96 100/100 100/100 100/100 100/100 100/100
G4: NAC before (POX + PAM) 1/2 17/71 33/75 38/79 42/79 42/88 50/92 50/92
G5: (POX + PAM) 1/2 8/75 8/79 13/79 17/79 25/79 25/83 29/83
G6: GSH before (POX + PAM) 1/2 67/46 67/67 71/92 75/96 83/90 83/96 88/96
G7: GSH before POX 1/2 92/83 92/92 96/92 100/92 100/96 100/96 100/96
G8: AA before (POX + PAM) 1/2 58/83 63/83 75/88 79/92 96/92 96/92 96/96
G9: AA before POX 1/2 58/75 67/83 75/83 75/83 75/92 83/100 83/100
Table 3: Cox analysis of the cumulative relative risk (RR) of death
for co-administration of compounds, including 95% confidence
interval (CI), of animals exposed to the paraoxon (POX) and
adjusted for POX dose (high/low).
Groups RR ± SD 95% CI Significance
POX only 1 0-0
POX + PAM + NAC 0.66 ± 15 0.42–0.91 𝑃 < 0.05
POX + NAC 1.04 ± 0.04 0.97–1.12 NS
POX + PAM 0.33 ± 0.03 0.23–0.43 𝑃 < 0.05
POX + PAM + GSH 0.81 ± 0.13 0.61–1.02 𝑃 < 0.05
POX + GSH 1.08 ± 0.03 1.03–1.14 NS
POX + PAM + AA 1.30 ± 0.12 1.10–1.49 𝑃 < 0.05
POX + AA 0.85 ± 0.28 0.00–3.32 𝑃 < 0.05
Table 4: Cox analysis of the cumulative relative risk (RR) of death
for pretreatment protocol, including 95% confidence interval (CI),
of animals exposed to the paraoxon (POX) and adjusted for POX
dose (high/low).
Groups RR ± SD 95% CI Significance
POX only 1 0-0 —
PAM before
POX 0.34 ± 0.19 0.04–0.64 𝑃 < 0.05
NAC before
POX 1.31 ± 0.24 0.93–1.70 NS
NAC before
(POX + PAM) 0.63 ± 0.15 0.39–0.86 𝑃 < 0.05
POX + PAM 0.47 ± 0.17 0.20–0.74 𝑃 < 0.05
GSH before
(POX + PAM) 0.93 ± 0.30 0.45–1.41 NS
GSH before
POX 0.84 ± 0.39 0.94–1.48 𝑃 < 0.05
AA before
(POX + PAM) 1.29 ± 0.18 1.01–1.57 𝑃 < 0.05
AA before POX 1.09 ± 0.30 0.00–4.08 NS
oxidative stress parameters revealed oxidative stress in many
OPC-induced subjects, including experimental rats andmice.
However, there is no convincing evidence for the use of
NEAO in acute OPC-poisoning with survival endpoint. It
has also been overlooked that each OPC has unique toxicity
profile and the hypothesis/concept may not be generalized
for all OPCs. The present study was conducted without
atropine to quantify the possible beneficial effect of three
antioxidants. Recently, Yurumez et al. [3] determined the
beneficial effect of NAC against organophosphate fenthion
toxicity (a moderately toxic OPC) in mice and demonstrated
that NAC has prophylactic as well as therapeutic activity in
OPC poisoning and clearly improves survival rates in mice
at a higher dose of NAC. It is not clear whether improved
survival rate is due to the antioxidant nature of NAC or some
other mechanism is involved. Shadnia et al. [14] used NAC
in a clinical trial of an OPC-poisoning case. Type of OPC
was not identified in the trial. They found that the group
which received NAC needed significantly less atropine than
the other one without NAC. The other antioxidants used for
OP-induced toxicity are Vitamins C and E, melatonin, and so
forth, but only on cellular level and biochemical estimation of
oxidative stress parameters.There are also conflicting reports
for the oxidative stress produced by OPCs under acute toxic
condition. Kose et al. [24] concluded that acute dichlorvos
administration did not cause marked oxidative stress and
probably does not play a major role in dichlorvos-induced
poisoning. Gunay et al. [25] reported no evidence of oxidative
stress due to dichlorvos in an acute study on rats. Mostafalou
et al. [10] worked on rats hepatocytes treated with a slightly
toxic group of OPC, malathion and concluded that the main
cause of cell death wasmitochondrial dysfunction and reduc-
tion of ROS is not sufficient for cell survival. Furthermore,
in response to changes in the intracellular environment,
mitochondria become producers of excessive reactive oxygen
species and release prodeath proteins, resulting in disrupted
ATP synthesis and activation of cell death pathways [26].
Our results show that concurrent application of POX + PAM
produced better protection than POX + PAM + antioxidant
whichmay be due to the interference of antioxidants with the
effect of PAM.
There may be many possible mechanisms to elaborate the
failure of NEAO in acute paraoxon poisoning. For instance,
mechanistically, loading of NEAO may not have come in
systemic circulation or its concentrationmight be so high that
the body cannot compensate it in a short period [13]. Another
possibility is that the oxidant produced during acute intoxi-
cation by paraoxon is not scavenged by these NEAOs because
they may be under the control of enzymatic antioxidants.
Oxidative Medicine and Cellular Longevity 5
Furthermore, radical scavengers like ascorbic acid can be pro-
oxidant [27]. According to Galley et al. [28] under severe
oxidant stress, vitamin C can function as a pro-oxidant by
promoting iron-catalyzed reactions.The systemic review and
meta-analysis conducted by Bjelakovic et al. [29] found no
evidence to support antioxidant supplements for primary or
secondary prevention in patientswith various diseases caused
by oxidative stress. In short, adjunct treatment with NEAOs
is not beneficial in acute poisoning of OPC for survival
outcome. However based on evidence from the literature,
it may be speculated that the use of antioxidants may be
beneficial in chronic exposure of OPC which causes different
pathophysiological conditions due to oxidative stress.
5. Conclusion
NEAOs like NAC, glutathione, and ascorbic acid have no
beneficial role in the survival of rats in acute toxicity with
paraoxon. Oxime treatment without the use of antioxidants
has been found more effective. The understanding of types
of oxidants and mechanism of their action during acute
cholinergic crises may help to select suitable and effective
antioxidants. Moreover, the different toxic dynamics of diver-
sified OPCs should not be overlooked.
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